Background For a full treatment course of severe malaria, community-administered pre-
referral rectal artesunate (RAS) should be completed by post-referral treatment consisting of …

Background For children below 6 years with suspected severe malaria attending a health
care provider unable to provide parenteral malaria treatment, pre-referral rectal artesunate …

Background The efficacy of artemisinin-based combination therapy (ACT) and rectal
artesunate for severe malaria in children is proven. However, acceptability of a package of …

Introduction Children who receive prereferral rectal artesunate (RAS) require urgent referral
to a health facility where appropriate treatment for severe malaria can be provided …

Abstract Background The Democratic Republic of the Congo adopted the strategy of using,
at the community level, a dose of rectal artesunate as a pre-referral treatment for severe …

Background Rectal artesunate, an efficacious pre-referral treatment for severe malaria in
children, was deployed at scale in Uganda, Nigeria, and DR Congo. In addition to …

Background To prevent child deaths from severe malaria, early parenteral treatment is
essential. Yet, in remote rural areas, accessing facilities offering parenteral antimalarials …

Background Severely ill patients with malaria with vomiting, prostration, and altered
consciousness cannot be treated orally and need injections. In rural areas, access to health …

Background Evidence suggests that pre-referral Rectal Artesunate (RAS) can be a life-
saving intervention for severe malaria in remote settings in Africa. Recognition of danger …

Background Successful pre-referral treatment with rectal artesunate (RA) for suspected
severe malaria requires operational linkages between community health workers (CHWs) …